Immediate Impact

4 from Science/Nature 77 standout
Sub-graph 1 of 21

Citing Papers

Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension
2022 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
2 intermediate papers

Works of Mark Robbins being referenced

Impact of Renal Denervation on Patients With Obstructive Sleep Apnea and Resistant Hypertension – Insights From the SYMPLICITY HTN-3 Trial –
2016
Incremental Prognostic Value of Elevated Baseline C-Reactive Protein Among Established Markers of Risk in Percutaneous Coronary Intervention
2001

Author Peers

Author Last Decade Papers Cites
Mark Robbins 690 450 129 221 25 986
Marco Comeglio 529 202 103 75 36 900
Akhil Parashar 852 249 145 227 37 1.1k
Laurie G. Futterman 497 285 124 84 44 747
Sheryl L. Chow 720 179 174 105 42 1.2k
Ambarish Pandey 760 204 107 169 43 1.1k
Emad Abu-Assi 580 145 39 88 47 787
Lawson McDonald 472 221 198 159 32 990
Wilbert S. Aronow 692 473 266 132 29 1.0k
Kenechukwu Mezue 619 187 222 146 42 1.1k
Joseph Soffer 450 201 33 75 18 779

All Works

Loading papers...

Rankless by CCL
2026